-
1.
公开(公告)号:EP3786187A1
公开(公告)日:2021-03-03
申请号:EP20201515.2
申请日:2014-08-01
发明人: LUCAS, Sophie , COULIE, Pierre , CUENDE VILLASUR, Julia , DUMOUTIER, Laure , RENAULD, Jean-Christophe , VAN DER WONING, Sebastian , SAUNDERS, Michael , DE HAARD, Hans , DE BOECK, Gitte
摘要: The present invention relates to a protein binding to GARP in the presence of TGF-β and uses thereof.
-
公开(公告)号:EP3027650A1
公开(公告)日:2016-06-08
申请号:EP14748185.7
申请日:2014-08-01
发明人: LUCAS, Sophie , COULIE, Pierre , CUENDE VILLASUR, Julia , DUMOUTIER, Laure , RENAULD, Jean-Christophe , VAN DE WONING, Sebastian , SAUNDERS, Michael , DE HAARD, Hans , DE BOECK, Gitte
CPC分类号: C07K16/2875 , A61K2039/505 , C07K16/28 , C07K16/30 , C07K2317/22 , C07K2317/24 , C07K2317/31 , C07K2317/32 , C07K2317/41 , C07K2317/54 , C07K2317/55 , C07K2317/565 , C07K2317/569 , C07K2317/622 , C07K2317/624 , C07K2317/626 , C07K2317/76 , C07K2317/92
摘要: The present invention relates to an antibody binding to the transmembrane protein ‘glycoprotein A repetitions predominant’ (GARP) in the presence of TGF-β and uses thereof.
摘要翻译: 本发明涉及在TGF-β存在下与跨膜蛋白“重复占优势”(GARP)结合的抗体及其用途。
-
公开(公告)号:EP3253796A1
公开(公告)日:2017-12-13
申请号:EP16710325.8
申请日:2016-02-02
发明人: SAUNDERS, Michael , COULIE, Pierre , LUCAS, Sophie , DE BOECK, Gitte , VAN DE WONING, Sebastian , DE HAARD, Hans
IPC分类号: C07K16/28 , C07K16/22 , A61K39/395 , A61P37/02
CPC分类号: C07K16/22 , A61K2039/505 , C07K16/2863 , C07K2317/22 , C07K2317/32 , C07K2317/33 , C07K2317/34 , C07K2317/55 , C07K2317/76 , C07K2317/92
摘要: The present disclosure relates to a protein binding to GARP in the presence of TGF-β and uses thereof.
-
公开(公告)号:EP4023674A3
公开(公告)日:2022-10-05
申请号:EP21208038.6
申请日:2017-07-14
申请人: Argenx BVBA
发明人: BLANCHETOT, Christophe Frederic Jerome , URSØ, Birgitte , SKAK-NIELSEN, Tine , BERTELSEN, Malene , VAN DER WONING, Sebastian , SAUNDERS, Michael , DE HAARD, Johannes Joseph Wilhelmus
IPC分类号: C07K16/28
摘要: The present invention relates to antibodies and antigen binding fragments thereof which bind to the cytokine receptor IL-22R, particularly human IL-22R. The invention also relates to pharmaceutical compositions comprising said antibodies or antigen binding fragments thereof, and methods of treating psoriasis, psoriatic arthritis or atopic dermatitis.
-
公开(公告)号:EP3774905A1
公开(公告)日:2021-02-17
申请号:EP19718651.3
申请日:2019-04-12
申请人: argenx BVBA , VIB VZW , Universiteit Gent
-
公开(公告)号:EP4023674A2
公开(公告)日:2022-07-06
申请号:EP21208038.6
申请日:2017-07-14
申请人: Argenx BVBA
发明人: BLANCHETOT, Christophe Frederic Jerome , URSØ, Birgitte , SKAK-NIELSEN, Tine , BERTELSEN, Malene , VAN DER WONING, Sebastian , SAUNDERS, Michael , DE HAARD, Johannes Joseph Wilhelmus
IPC分类号: C07K16/28
摘要: The present invention relates to antibodies and antigen binding fragments thereof which bind to the cytokine receptor IL-22R, particularly human IL-22R. The invention also relates to pharmaceutical compositions comprising said antibodies or antigen binding fragments thereof, and methods of treating psoriasis, psoriatic arthritis or atopic dermatitis.
-
公开(公告)号:EP3484921A1
公开(公告)日:2019-05-22
申请号:EP17746011.0
申请日:2017-07-14
申请人: Argenx BVBA
发明人: BLANCHETOT, Christophe Frederic Jerome , URSØ, Birgitte , SKAK-NIELSEN, Tine , BERTELSEN, Malene , VAN DER WONING, Sebastian , SAUNDERS, Michael , DE HAARD, Johannes Joseph Wilhelmus
IPC分类号: C07K16/28
-
-
-
-
-
-